White House press secretary Jen Psaki discussed the partnership between longtime competitors Merck and Johnson & Johnson to ramp up production of the single-shot J&J vaccine, which was greenlighted by the Food and Drug Administration Saturday.
"The two largest health care and pharmaceutical companies, Merck and Johnson & Johnson, usually competitors, are coming together to expand production of the vaccine, Johnson & Johnson’s vaccine drug substance, as well as increase its fill finish capacity," Psaki said. "They will enter into a historic manufacturing partnership to expand that, I should say."
Psaki touted the White House's role in getting the companies to work together, saying it "speaks to the ability of this administration, broadly, to bring them to the table and work together to address the pandemic in the country." She also discussed how the federal government is working to facilitate making the vaccine available, including providing support from the Department of Defense and using the Defense Production Act.
"The US Government will facilitate this partnership in several key ways including invoking the Defense Production Act to equip two Merck facilities to the standards necessary, safely manufacture the vaccine, and asking the Department of Defense to provide daily logistical support to strengthen Johnson & Johnson's efforts," Psaki said.